These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11929585)
21. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway. Paradela A; Alvarez I; García-Peydró M; Sesma L; Ramos M; Vázquez J; López De Castro JA J Immunol; 2000 Jan; 164(1):329-37. PubMed ID: 10605027 [TBL] [Abstract][Full Text] [Related]
22. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. Kollnberger S; Bird LA; Roddis M; Hacquard-Bouder C; Kubagawa H; Bodmer HC; Breban M; McMichael AJ; Bowness P J Immunol; 2004 Aug; 173(3):1699-710. PubMed ID: 15265899 [TBL] [Abstract][Full Text] [Related]
23. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex. Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497 [TBL] [Abstract][Full Text] [Related]
24. Relationship between peptide binding and T cell epitope selection: a study with subtypes of HLA-B27. Lamas JR; Brooks JM; Galocha B; Rickinson AB; López de Castro JA Int Immunol; 1998 Mar; 10(3):259-66. PubMed ID: 9576613 [TBL] [Abstract][Full Text] [Related]
25. Modulation on immunogenicity by HLA-B27 subtype polymorphism. Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494 [TBL] [Abstract][Full Text] [Related]
26. The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation. Alvarez I; Martí M; Vázquez J; Camafeita E; Ogueta S; López de Castro JA J Biol Chem; 2001 Dec; 276(52):48740-7. PubMed ID: 11673468 [TBL] [Abstract][Full Text] [Related]
28. Structure and immune recognition of HLA-B27 antigens: implications for disease association. López de Castro JA; Bragado R; Lauzurica P; López D; Rojo S Scand J Rheumatol Suppl; 1990; 87():21-31. PubMed ID: 1701918 [TBL] [Abstract][Full Text] [Related]
29. Distribution of HLA-B27 in Romanian spondyloarthritides patients. Popa OM; Bojinca M; Bojinca V; Ciofu C; Dutescu MI; Bardan A; Sfrent-Cornateanu R; Petrek M; Bara C; Popa L Int J Immunogenet; 2010 Dec; 37(6):513-6. PubMed ID: 20572892 [TBL] [Abstract][Full Text] [Related]
30. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines. Crotzer VL; Christian RE; Brooks JM; Shabanowitz J; Settlage RE; Marto JA; White FM; Rickinson AB; Hunt DF; Engelhard VH J Immunol; 2000 Jun; 164(12):6120-9. PubMed ID: 10843661 [TBL] [Abstract][Full Text] [Related]
31. Major histocompatibility genes and ankylosing spondylitis. Reveille JD Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):601-9. PubMed ID: 16777585 [TBL] [Abstract][Full Text] [Related]
32. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791 [TBL] [Abstract][Full Text] [Related]
33. Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation. Tedeschi V; Alba J; Paladini F; Paroli M; Cauli A; Mathieu A; Sorrentino R; D'Abramo M; Fiorillo MT Cells; 2019 Jun; 8(6):. PubMed ID: 31212633 [TBL] [Abstract][Full Text] [Related]
34. The role of HLA-B27 in spondyloarthritis. Taurog JD J Rheumatol; 2010 Dec; 37(12):2606-16. PubMed ID: 21123333 [TBL] [Abstract][Full Text] [Related]
35. Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism. Galocha B; Lamas JR; Villadangos JA; Albar JP; López de Castro JA Tissue Antigens; 1996 Nov; 48(5):509-18. PubMed ID: 8988533 [TBL] [Abstract][Full Text] [Related]
36. HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similar to bacteria-derived peptides. Frauendorf E; von Goessel H; May E; Märker-Hermann E Clin Exp Immunol; 2003 Nov; 134(2):351-9. PubMed ID: 14616798 [TBL] [Abstract][Full Text] [Related]
37. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Marcilla M; López de Castro JA Tissue Antigens; 2008 Jun; 71(6):495-506. PubMed ID: 18489433 [TBL] [Abstract][Full Text] [Related]
38. Effect of the substitution of critical residues on the allorecognition of HLA-B27. Ozen S; Clayberger C; Krensky AM; Benjamin R Clin Exp Rheumatol; 1992; 10(6):583-7. PubMed ID: 1282853 [TBL] [Abstract][Full Text] [Related]
39. Dendritic cells in the pathogenesis of ankylosing spondylitis and axial spondyloarthritis. Slobodin G; Rosner I; Kessel A Clin Rheumatol; 2019 May; 38(5):1231-1235. PubMed ID: 30519775 [TBL] [Abstract][Full Text] [Related]
40. Endogenous processing and presentation of T-cell epitopes from Chlamydia trachomatis with relevance in HLA-B27-associated reactive arthritis. Cragnolini JJ; García-Medel N; de Castro JA Mol Cell Proteomics; 2009 Aug; 8(8):1850-9. PubMed ID: 19443418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]